Literature DB >> 15280019

Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris.

Weon-Kyoo You1, Won-Seok Choi, You-Seok Koh, Hang-Cheol Shin, Yangsoo Jang, Kwang-Hoe Chung.   

Abstract

A thrombin-like enzyme of Bothrops atrox moojeni venom, batroxobin, specifically cleaves fibrinogen alpha chain, resulting in the formation of non-crosslinked fibrin clots. The cDNA encoding batroxobin was cloned, expressed in Pichia pastoris and the molecular function of purified recombinant protein was also characterized. The recombinant batroxobin had an apparent molecular weight of 33 kDa by SDS-PAGE analysis and biochemical activities similar to those of native batroxobin. The purified recombinant protein strongly converted fibrinogen into fibrin clot in vitro, and shortened bleeding time and whole blood coagulation time in vivo. However, it did not make any considerable alterations on other blood coagulation factors. Several lines of experimental evidence in this study suggest that the recombinant batroxobin is a potent pro-coagulant agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280019     DOI: 10.1016/j.febslet.2004.06.060

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Hemocoagulase might not control but worsen gastrointestinal bleeding in an elderly patient with type II respiratory failure.

Authors:  Xingshun Qi; Jigang Wang; Xiaonan Yu; Valerio De Stefano; Hongyu Li; Chunyan Wu; Qingwei Zeng; Yongguo Zhang; Linan Ren; Hao Lin; Jiao Deng; Xiaozhong Guo
Journal:  Transl Gastroenterol Hepatol       Date:  2017-09-12

2.  Antithrombotic Effects of Amaranthus hypochondriacus Proteins in Rats.

Authors:  Ana Clara Sabbione; Gustavo Rinaldi; María Cristina Añón; Adriana A Scilingo
Journal:  Plant Foods Hum Nutr       Date:  2016-03       Impact factor: 3.921

3.  Batroxobin protects against spinal cord injury in rats by promoting the expression of vascular endothelial growth factor to reduce apoptosis.

Authors:  Hui Yu; Bin Lin; Yongzhi He; Wenbin Zhang; Yang Xu
Journal:  Exp Ther Med       Date:  2015-03-17       Impact factor: 2.447

4.  Protective effects of Batroxobin on spinal cord injury in rats.

Authors:  Hong Fan; Xia Liu; Hai-Bin Tang; Peng Xiao; Ya-Zhou Wang; Gong Ju
Journal:  Neurosci Bull       Date:  2013-07-13       Impact factor: 5.203

Review 5.  Therapeutic potential of snake venom in cancer therapy: current perspectives.

Authors:  Vivek Kumar Vyas; Keyur Brahmbhatt; Hardik Bhatt; Utsav Parmar
Journal:  Asian Pac J Trop Biomed       Date:  2013-02

6.  Effectiveness of topical haemocoagulase as a haemostatic agent in children undergoing extraction of primary teeth: a split-mouth, randomised, double-blind, clinical trial.

Authors:  D F Swamy; E S Barretto; J S L Rodrigues
Journal:  Eur Arch Paediatr Dent       Date:  2019-03-21

7.  Ontogenetic Variation in Biological Activities of Venoms from Hybrids between Bothrops erythromelas and Bothrops neuwiedi Snakes.

Authors:  Marcelo Larami Santoro; Thaís do Carmo; Bruna Heloísa Lopes Cunha; André Fonseca Alves; André Zelanis; Solange Maria de Toledo Serrano; Kathleen Fernandes Grego; Savio Stefanini Sant'Anna; Katia Cristina Barbaro; Wilson Fernandes
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

8.  Proteomic Analyses of Agkistrodon contortrix contortrix Venom Using 2D Electrophoresis and MS Techniques.

Authors:  Aleksandra Bocian; Małgorzata Urbanik; Konrad Hus; Andrzej Łyskowski; Vladimír Petrilla; Zuzana Andrejčáková; Monika Petrillová; Jaroslav Legáth
Journal:  Toxins (Basel)       Date:  2016-12-13       Impact factor: 4.546

9.  Correlation between the glycan variations and defibrinogenating activities of acutobin and its recombinant glycoforms.

Authors:  Ying-Ming Wang; Inn-Ho Tsai; Jin-Mei Chen; An-Chun Cheng; Kay-Hooi Khoo
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

10.  Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.

Authors:  Reheman Adili; Madeline Jackson; Livia Stanger; Xiangrong Dai; Mandy Li; Benjamin Xiaoyi Li; Michael Holinstat
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.